This study aimed to elucidate the endocrine outcome of craniopharyngioma surgery. In particular, endocrine results were analyzed in relation to the surgical approach. The study includes 161 patients who underwent pre-and postoperative endocrine assessment, 143 of whom had not previously undergone surgery.
endocrine deficiency are well-known features of craniopharyngiomas. However, only a few series have demonstrated the actual frequency of endocrine deficiency associated with craniopharyngiomas at presentation. [1, 2, 11, 17] Similarly, systematic studies addressing the endocrine outcome of craniopharyngioma surgery are rare. It is generally accepted that craniopharyngioma surgery results in a high rate of hypothalamopituitary dysfunction. [2, 4, 11, 16, 17] The effect of different surgical approaches on endocrine outcome has not been systematically analyzed. Furthermore, the published studies focusing on endocrine outcome have not considered intraoperative aspects of surgery. Intraoperative handling of the pituitary stalk and the pituitary gland fundamentally affects endocrine function. Therefore, we have assessed this function in 161 patients who underwent craniopharyngioma surgery. In particular, the influence of the surgical approach and of intraoperative findings on endocrine outcome has been addressed. Because late endocrine results of craniopharyngioma surgery alone are not available in the literature, we have also reviewed endocrine function during the later follow-up period.
CLINICAL MATERIAL AND METHODS

Patient Selection
Between January 1983 and April 1997, 168 patients underwent surgery for craniopharyngiomas at our department. Whereas complete pre-and postoperative data were available in all children, seven adult patients were excluded from the study because their endocrine data were incomplete. Of these, three patients died in the postoperative period, before endocrine reassessment could be performed. Two of these patients were undergoing treatment for a recurrent craniopharyngioma, and one harbored an additional large parophthalmic aneurysm that was clipped during craniopharyngioma surgery. This last patient was excluded because the pre-and postoperative endocrine deficiency could not be assigned with certainty to the craniopharyngioma. Four of the patients who underwent limited surgery (that is, stereotactically guided cyst puncture and/or cerebrospinal fluid drainage by means of shunt placement) were not reassessed postoperatively for endocrine function.
The remaining 161 patients (77 females and 84 males) who underwent complete pre-and postoperative endocrine evaluation were included in the study. Of these, 36 were children (lt 16 years old) and 125 were adults. Surgery was initially administered at our institution in 143 patients (primary surgery group), of whom 14 required a second surgical procedure during the follow-up period. The remaining 18 patients had undergone surgery elsewhere and were referred to our department for repeat operation to treat a recurrent craniopharyngioma. All repeat operations were transcranial or transsphenoidal procedures (minor operations such as cyst decompression were only included if they constituted the initial therapy). Of the 143 patients in the primary surgery group, a transcranial approach was chosen in 92. Twelve of them underwent combined surgery (a second transcranial or an additional transsphenoidal procedure). In 35 patients, transsphenoidal surgery was performed. During these 127 primary open surgical procedures, craniopharyngioma removal was total in 73 cases, subtotal in 32, partial in 21, and in one case only a biopsy specimen was taken. Complete removal was accomplished in 85.7% of primary transsphenoidal procedures and in 46.7% of primary transcranial procedures. The remaining 16 patients underwent limited surgery (stereotactically guided cyst puncture, and/or biopsy, and/or cerebrospinal fluid shunt placement).
Eleven of 32 recurrent craniopharyngiomas were totally removed, and resection was subtotal or partial in the other 21 tumors.
Endocrinological Evaluation
Endocrine function was assessed preoperatively, 1 week postsurgery, and 3 months postsurgery.
Anterior Pituitary Function. For evaluation of anterior pituitary function, dynamic stimulation was performed with an intravenous bolus injection of 250 µg of adrenocorticotropic hormone (ACTH) (Synacthen, Ciba-Geigy, Wehr, Germany), 200 µg of thyrotropin-releasing hormone (Relefact, Hoechst, Bad Soden, Germany), and 100 µg of gonadotropin-releasing hormone (Relefact LH-RH, Hoechst). Basal and stimulated (30-minute) cortisol, thyroid-stimulating hormone, luteinizing hormone, and follicle-stimulating hormone were measured in the serum, as were the basal levels of prolactin, T 3 , T 4 , and also estradiol or testosterone according to the patient's gender. Measurement of ACTH provides indirect information on hypothalamopituitary regulation of the adrenal axis. However, the results are closely correlated with those of an insulin tolerance test [18] or a corticotropin-releasing hormone stimulation test. Stimulation of ACTH is therefore a rational, less time-consuming alternative for routine practice. An additional preoperative insulin tolerance test for assessment of the growth-hormone (GH) and adrenal axes was performed in 86 patients. A trough blood glucose value of less than 40 mg/dl was considered to be an adequate level of hypoglycemia.
The basal values for the hormones we tested were assigned according to the manufacturers' instructions. An increase in cortisol of less than 7 µg/dl over the basal value or a value of less than 18 µg/dl during ACTH stimulation indicated adrenal insufficiency. [5] During an insulin tolerance test, an increase in cortisol levels of less than 12 µg/dl was considered subnormal. Hypothyroidism was diagnosed in the presence of low levels of thyroid hormones associated with normal or blunted thyroid-stimulating hormone response. A less than threefold increase in luteinizing hormone and a less than twofold increase in follicle-stimulating hormone after administration of gonadotropin-releasing hormone was compatible with hypogonadism. A GH deficiency was diagnosed when its levels were less than 7 ng/ml during an insulin tolerance test.
Posterior Pituitary Function. Fluid intake and urine output were monitored in all patients. Measurements of the specific gravity of the urine were taken for at least 7 days postoperatively. Beginning in 1991, urine and serum osmolarity were measured before, 1 week after, and 3 months postsurgery after the patients had fasted overnight. Serum osmolarity was considered normal in the range of 280 to 295 mosmol/kg. For an assessment of posterior pituitary function, a urine osmolarity value at least twice that of the serum osmolarity was required.
Furthermore, clinical signs and symptoms of endocrine deficiency were evaluated by means of a standardized questionnaire and physical examination. In females, assessments of menstrual cycle abnormalities (for example oligomenorrhea or amenorrhea) were important for evaluation of the gonadal axis in addition to measurements of hormone levels. Height was documented with growth charts.
Postoperative results after 1 week were important for the initial adjustment of hormone replacement therapy and provided a fairly reliable estimate of endocrine deficiency. For definitive evaluation of postoperative endocrine results, reassessment at 3 months postoperatively was of paramount importance.
Follow-Up Evaluation
The mean follow-up period for endocrine reassessment was 61.2 months (median 49 months, range 1-175 months). Most patients received follow-up care in our outpatient department, although some patients were also seen by endocrinologists. Endocrine follow-up data were taken from our own charts or from letters from the patients' endocrinologists. Children generally received follow-up care from pediatric endocrinologists. For evaluation of postoperative growth, we have reviewed the patients' growth charts and have assessed the frequency of GH replacement therapy.
RESULTS
Presenting Complaints
In 28.7% of our patients, symptoms related to endocrine deficiency prompted medical consultation ( Table 1 ). The only major presenting symptom that occurred more frequently was vision problems.
Only 4.9% of patients overall and only 3.3% of the children sought medical attention for diabetes insipidus (Table 1) . Delayed puberty and growth retardation dominated among presenting endocrine symptoms. Surprisingly, delayed puberty and growth were the presenting complaints in only 20% of the children. Frequently, patients with these signs were found to harbor a craniopharyngioma when they had reached adulthood.
In patients with tumors suitable for transsphenoidal surgery, endocrine symptoms clearly prevailed (Table 1 ). In this subgroup of patients, 62.9% presented with endocrine symptoms, which were much more common than visual complaints. In contrast, 59.8% of the patients who underwent transcranial surgery presented with visual failure but only 20.6% exhibited endocrine deficiency.
Preoperative Endocrinological Findings
Clinical workup revealed diabetes insipidus in 16.1% of the patients with no prior surgery ( Table 2) . Secondary adrenal failure (ACTH deficiency) and secondary hypothyroidism were observed in 31.5% and 24.5% of patients, respectively. Secondary hypogonadism, which was found in 77.4% of cases, was by far a more frequent finding. Hypothalamohypophysial disconnection with consecutive hyperprolactinemia was found in 41.3% of our patients at initial presentation. Of the postpubertal patients, 20 (16.1%) of 124 presented with no anterior or posterior pituitary deficiency. The rate of diabetes insipidus, adrenal failure, and hypothyroidism was slightly lower in children (Table 3) .
Endocrine findings in patients who underwent transcranial surgery were significantly different from those in patients with tumors suitable for transsphenoidal surgery (Tables 4 and 5 ). The rate of pituitary failure was much higher in the transsphenoidal group. The difference was most flagrant for the adrenal axis, which was deficient in 60% of the transsphenoidal group but in only 22.8% of the transcranial group. Only three patients (9%) in the transsphenoidal group showed no evidence of endocrine deficiency.
Growth Hormone. Growth hormone deficiency was observed in 59 (72%) of 82 patients in the primary surgery group who were assessed preoperatively by means of an insulin tolerance test. Similarly, 17 (73.9%) of 23 children were GH-deficient. However, short stature was found in only 46.7% of the children at initial presentation. Short stature was observed in 13.3% of the adult patients at the time of diagnosis (mean age 22.2 years). One patient with short stature was 62 years of age, and all others in this category were less than 27 years old.
In patients who had previously undergone surgery, the rate of anterior and posterior pituitary deficiency was already high at the time of tumor recurrence (Table 6 ). Only one of them presented with normal anterior and posterior pituitary function. (Table 7) , and it was preserved in 50 of these 62 patients. In four patients, the pituitary stalk was deliberately sacrificed to accomplish a complete surgical removal of the tumor. The stalk was partially sacrificed if part of it was distended and invaded by the craniopharyngioma.
Intraoperative Identification and Management of Pituitary Gland and Stalk
Transsphenoidal Surgery. In 21 (60%) of 35 patients undergoing primary transsphenoidal surgery, the pituitary gland was displaced ventrally by the tumor. After opening the basal dura, the pituitary gland was visualized. In these cases, the gland was incised in the midline for exposure of the craniopharyngioma. During transsphenoidal surgery, the pituitary stalk was identified in 12 of the 35 cases (Table 7) , and was sacrificed in only one case. In eight cases, the craniopharyngioma was adherent to the stalk, which was preserved when the tumor was excised.
Postoperative Endocrinological Findings at 3 Months
In the primary surgery group, a high rate of new postoperative diabetes insipidus was encountered (Table  2) ; the preoperative rate of 16.1% increased to 59.4% postsurgery. In one case only, preoperative diabetes insipidus resolved postsurgery. The rate of new adrenal and thyroid failure postoperatively was less pronounced. The percentage of hypogonadism increased slightly postsurgery. Improvement or complete recovery of preoperative anterior pituitary deficits was relatively rare (Table 2 ). In contrast, deterioration of an endocrine axis that was partially deficient preoperatively was relatively common. Hyperprolactinemia regressed in 30 cases postsurgery, but new postoperative disease was encountered in 16 other cases. Postoperative endocrine results were similar among the patients in whom total tumor removal was accomplished and those in whom resection was subtotal or partial.
The postoperative findings in children (Table 3) paralleled the results of the mixed series. In the primary transcranial surgery group, 50% of the patients exhibited new postoperative diabetes insipidus (Table 4) . However, as many as 33.7% of these patients still had normal posterior pituitary function postsurgery. New postoperative adrenal deficiency was found in 35.9% of patients, whereas the percentage of new postoperative deficiency was less pronounced for the thyroid and gonadal axes.
The postoperative rate of diabetes insipidus was 68.6% after transsphenoidal surgery (Table 5 ) and paralleled the rate found after transcranial surgery. In contrast, anterior pituitary function was generally preserved after a transsphenoidal procedure. Furthermore, preoperative hyperprolactinemia resolved in all but three cases after transsphenoidal surgery. Endocrine results were similar in the group of 21 patients in whom the pituitary gland was incised medially to expose the tumor.
Postoperative results were unchanged in the 16 patients undergoing conservative surgical procedures.
Adrenal function improved in only one case after stereotactically guided cyst decompression. Deterioration of endocrine function was not observed in any of these patients.
Identification and Preservation of the Pituitary Stalk.
In the primary transcranial group, no difference in endocrine results was found between the group of patients in whom the pituitary stalk was identified and preserved intraoperatively and the group in whom the stalk was not identified (Table 8 ). In patients in whom the pituitary stalk was partially sacrificed, the rate of postoperative diabetes insipidus was high. However, the rate of anterior pituitary failure was similar to that found in the group of patients in whom the stalk was totally preserved.
During transsphenoidal surgery, posterior pituitary function generally deteriorated after the procedure when the pituitary stalk was identified intraoperatively ( Table 9 ). The results were more favorable when the pituitary stalk was not identified. This discrepancy is explained by the fact that exposure of the stalk was required in patients in whom the tumor adhered to this structure. Sharp dissection of the capsule from the stalk was required in these cases. In contrast, no deterioration of anterior pituitary function resulted from dissection of the tumor at the stalk.
After surgery for tumor recurrence, the high preoperative rate of diabetes insipidus and adrenal failure increased further (Table 6 ). The overall rate of hypothyroidism and hypogonadism was not affected by repeat operation; one patient still had no endocrine deficiency after repeat surgery.
Endocrinological Function During Later Follow-Up Review
In general, the results of endocrine testing at 3 months postoperatively predicted the final endocrine outcome. However, in individual cases further improvement of hypothalamohypophysial function was observed during later follow-up review. The late results in 88 patients with no recurrence and who did not undergo radiotherapy are shown in Table 10 and are compared with the early results 3 months postoperatively. The mean follow-up duration in this group of patients was 50 months (range 3-164 months). Diabetes insipidus regressed in five patients during the later follow-up period and hormone replacement therapy was discontinued. Similarly, adrenal insufficiency fully resolved in three patients. Regression of hypogonadism was observed in only one patient. Additionally, adrenal and posterior pituitary function partially recovered in three and two patients, respectively. On the other hand, deterioration of endocrine function was not observed in any of these 88 patients (Table 10 ).
In contrast, in seven of 14 patients treated with early postoperative radiotherapy and who remained free of recurrence, anterior pituitary function deteriorated during the follow-up period, resulting in at least one additional deficient endocrine axis. Panhypopituitarism was found in six of these 14 patients at the final follow-up evaluation. The mean irradiation dose in these 14 patients was 54 Gy, and it was 49 Gy in those patients with endocrine deterioration.
Growth Hormone. Nine of 14 children presenting with short stature before undergoing primary surgery were started on GH therapy postsurgery. In two of these 14 children, GH was already being administered preoperatively, and the remaining three children were postpubertal. Only four of 16 children with normal preoperative height required postoperative GH replacement therapy. Eleven of these 16 children exhibited a normal growth velocity postsurgery without GH therapy, despite GH deficiency in one of them. One female patient was already postpubertal and had reached her adult height preoperatively. Only one of six children who were referred for repeat operation of a recurrent craniopharyngioma had a normal height and continued to grow after surgery without GH therapy. The other five children were already receiving GH replacement therapy at the time of referral.
DISCUSSION
We assessed endocrine features and outcome after surgery in 161 patients. Adult patients predominated but the series is otherwise unselected because all patients requiring therapy for craniopharyngiomas underwent surgery as the first therapeutic measure (primary surgery).
Preoperative Endocrinological Findings
Presenting Complaints. In our series, the frequency of visual compromise as the presenting complaint surpassed endocrine deficiency, which was the next most common complaint. A prevalence of visual symptoms has previously been shown in adults, [19] whereas children mostly present with headaches and signs of intracranial hypertension. [3, 19] Growth retardation is considered a characteristic symptom in children harboring craniopharyngiomas. Children frequently present with other complaints but short stature is found on examination.
[4] Additionally, we found short stature in a remarkable number of patients with craniopharyngiomas presenting in adulthood. Endocrine evaluation and neuroimaging should be ordered for patients presenting with otherwise unexplained growth delay, to allow earlier diagnosis of intracranial tumors.
Whereas visual symptoms clearly prevailed in our series of supradiaphragmatic craniopharyngiomas, endocrine symptoms were by far the most common presenting complaint (62.9%) in subdiaphragmatic craniopharyngiomas suitable for transsphenoidal surgery. One likely reason is the compression of the pituitary gland by intrasellar, subdiaphragmatic craniopharyngiomas.
Preoperative Endocrinological Evaluation.
There is agreement in the literature that approximately 75% of patients with craniopharyngiomas suffer from preoperative GH deficiency. [2, 11, 15] In our experience, the percentage of hypogonadotropic hypogonadism is similarly high. The rate of 77.4% seen in our study is in agreement with another recent, predominantly adult series that demonstrated hypogonadism in 82% of the cases. [11] A lower percentage is reported in some series of childhood craniopharyngiomas. [4, 15] The rate of preoperative ACTH deficiency and hypothyroidism reported for childhood craniopharyngiomas lies mostly in the range between 25% and 30%. [4, 15] These results concur with those of our predominantly adult series. In children, the incidence of diabetes insipidus is usually 10 to 20%. [2, 15] The incidence is apparently similar in series with a prevalence of adults as shown in the literature [1] and confirmed by us.
We have directly compared endocrine function in children with that found in the entire series, and no major differences were detected. Consistent with the presenting complaints, formal endocrinological evaluation revealed a significantly higher incidence of pituitary failure in the group ofpatients who had subdiaphragmatic craniopharyngiomas suitable for transsphenoidal surgery.
Postoperative Endocrinological Findings
After Transcranial Surgery. A high rate of postoperative pituitary deficiency and even of panhypopituitarism [4, 11, 17, 20] has been reported in surgical series in which the predominant or exclusive surgical approach was transcranial. In our series, we found that diabetes insipidus was the most common additional postoperative deficiency after transcranial surgery. Yasargil, et al., [21] who performed radical excision in all cases, observed permanent diabetes insipidus in 78.7% of their patients. In contrast to most reports in the literature, we observed only a moderate increase in anterior pituitary deficiency as a surgical sequela. Normal preoperative anterior pituitary function was more often maintained than deficient postsurgery. Preservation of greater than 50% of anterior pituitary functions was also accomplished by Baskin and Wilson [1] who reported on a mixed transcranial/transsphenoidal series.
The discrepancies in endocrine outcome in transcranial surgery reported in the literature might be partially explained by technical aspects of the surgery. Previous studies have not mentioned whether the pituitary stalk was sacrificed intraoperatively. Only Yasargil, et al., [21] described in detail how often the pituitary stalk was identified and preserved during transcranial surgery. In craniopharyngioma surgery, the pituitary stalk is a crucial structure because the tumor often originates from there. The attempt to preserve the stalk is a time-consuming and sometimes demanding effort, but it is rewarded with improved endocrine results. Even if the stalk is only partially preserved, pituitary function may be restored. It has been reported in the literature that the degree of postoperative endocrine deficiency depends on the extent of tumor removal. [3, 16] In our series, the early endocrine results were also more favorable in patients undergoing cyst decompression only compared with the groups of patients undergoing transcranial or transsphenoidal surgery. Of course, endocrine function is only at risk if the solid tumor and capsule are dissected from structures that regulate this function. On the other hand, the endocrine results were similar in the transcranial group whether or not complete removal was accomplished. Our general approach is to remove as much of the tumor as possible. In following this policy, we found that the factors determining complete or incomplete tumor removal (for example, adherence of the capsule to intracranial vessels) have no influence on endocrine outcome.
After Transsphenoidal Surgery. We have shown that residual anterior pituitary function is frequently preserved after transsphenoidal surgery. However, we observed improvement in a preexisting deficiency only rarely. [7] In contrast, König, et al., [8] found a 19% chance of normalizing impaired anterior pituitary function by means of transsphenoidal surgery, but they made no attempt to remove the suprasellar capsule because they wanted to avoid damage to the pituitary stalk. In our opinion, complete removal should have priority. We found that sharp excision of the capsule from the stalk results in a high rate of postoperative diabetes insipidus, which is acceptable to accomplish a total tumor removal. However, Landolt and Zachmann [9] observed a relatively low incidence of new postoperative diabetes insipidus, but a high risk of postoperative anterior pituitary failure after transsphenoidal surgery. We cannot readily account for this discrepancy with our results.
Laws [10] emphasized that the pituitary gland is often displaced ventrally and inferiorly and is easily injured by the transsphenoidal approach. He concluded that this approach is therefore less desirable in patients with normal pituitary function. We have shown that endocrine outcome is not inferior in those patients in whom the gland was found ventrally and was incised during transsphenoidal surgery. Consequently, the transsphenoidal approach can be recommended regardless of preoperative endocrine function, because the overall endocrine results of surgery via the transsphenoidal approach are better than those found in transcranial surgery.
Late Results. External conventional radiotherapy carries a high risk of delayed endocrine deficiency of anterior pituitary functions, and endocrine function gradually deteriorates with time. [4] The effect depends on the radiation dose. [13] Direct comparison of endocrine results between patients treated surgically and those treated by means of radiotherapy is difficult. The rate of diabetes insipidus is generally higher postsurgery, as has been reported mainly in children. [3, 6, 20] We have shown that the rate of postoperative diabetes insipidus is not much different in adults. Improvement of pituitary function after intracavitary irradiation has been described. [12] However, in the long-term follow-up evaluation of patients who were preferentially treated with intracavitary irradiation, 68% were found to have panhypopituitarism. [14] The long-term endocrine results after surgery alone have not been described in the literature. We have shown that no endocrine deterioration is observed during follow-up review in patients with no tumor recurrence. There is even a chance of further recovery; diabetes insipidus and adrenal failure regressed in some of our patients.
